🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 15 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/06/2006 23,52 24,90 22,74 23,34 -0,26% 9,18% 122.783
15/06/2006 24,24 24,24 22,62 23,40 -2,26% 6,68% 127.583
14/06/2006 23,46 24,12 22,50 23,94 +1,53% 6,91% 145.317
13/06/2006 22,80 23,82 21,18 23,58 +2,34% 11,58% 210.017
12/06/2006 25,08 25,08 20,70 23,04 -7,69% 17,46% 578.117
09/06/2006 25,80 26,04 24,78 24,96 -2,80% 4,88% 79.533
08/06/2006 26,04 26,04 24,60 25,68 -0,70% 5,53% 153.000
07/06/2006 25,68 26,82 25,56 25,86 +0,70% 4,91% 74.100
06/06/2006 26,10 26,64 25,44 25,68 -2,06% 4,60% 125.767
05/06/2006 26,88 28,08 26,16 26,22 -2,24% 7,14% 101.100
02/06/2006 27,12 27,84 26,76 26,82 -1,32% 3,98% 90.833
01/06/2006 27,54 27,60 25,92 27,18 -0,44% 6,10% 61.200
31/05/2006 27,84 27,90 26,10 27,30 -1,94% 6,47% 156.017
30/05/2006 28,32 28,56 27,66 27,84 -2,73% 3,18% 97.317
26/05/2006 29,28 29,28 28,44 28,62 -1,24% 2,87% 113.283
25/05/2006 28,38 28,98 27,42 28,98 +4,09% 5,50% 159.217
24/05/2006 29,88 30,42 27,66 27,84 +0,43% 9,24% 315.567
23/05/2006 27,96 29,10 27,24 27,72 +0,22% 6,65% 177.067
22/05/2006 28,56 29,58 27,00 27,66 -4,16% 9,03% 149.550
19/05/2006 27,60 29,70 27,24 28,86 +4,57% 8,91% 493.433
18/05/2006 26,10 27,72 25,86 27,60 +5,50% 7,13% 236.967
17/05/2006 26,40 26,46 24,78 26,16 -1,36% 6,36% 281.033
16/05/2006 27,60 27,66 25,20 26,52 -3,91% 8,91% 408.617
15/05/2006 29,10 29,16 27,12 27,60 -5,35% 7,01% 290.800
12/05/2006 26,40 29,64 24,48 29,16 +10,45% 19,55% 848.217
11/05/2006 29,70 30,00 26,04 26,40 -10,20% 13,33% 696.233
10/05/2006 35,34 35,46 28,38 29,40 -32,51% 20,03% 2.408.633
09/05/2006 41,88 43,98 41,10 43,56 +8,04% 6,88% 909.717
08/05/2006 37,20 40,38 37,20 40,32 +8,04% 8,55% 258.117
05/05/2006 37,44 37,44 36,30 37,32 -1,11% 3,04% 197.017